Frontiers
US$ 24.68
tirzepatide pregnancy breastfeeding guidance Returning to while breastfeeding? π¨ New Research Alert: Tirzepatide
Description
Plateaus lasting 2 to 6 weeks are normal and do not indicate dose inadequacy
If you feel more comfortable receiving the treatment at our clinic, you will need to return once a week to receive the injection
Provenance and peer review Not commissioned, externally peer-reviewed
Our published outcomes from a 2025 JMIR Formative Research study show an average 19.1% body weight loss at 12 months among active subscribers, with 77.7% achieving at least 10% weight loss
